Kalaris Therapeutics, Inc. (KLRS)
Market Open
11 Sep, 15:19
NASDAQ (NMS) NASDAQ (CM) Primary NASDAQ (NMS) $
3. 38
+0.08
+2.5758%
$
87.9M Market Cap
- P/E Ratio
- Div Yield
21,809 Volume
-1.75 Eps
$ 3.3
Previous Close Investors:
Want to track KLRS and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Kalaris Therapeutics, Inc. Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
| JD Jim Dushek HARBOUR INVESTMENTS Inc. | 13 | $75.01 | $43.94 | -$31.07 | -41.42% |
 Shawn M. McHugh WealthTrust Asset Management LLC | 20,416 | $106,840.32 | $69,108.16 | -$37,732.16 | -35.32% |
 Belena Vincetti Fortis Capital Advisors LLC | 40,000 | $231,200 | $134,800 | -$96,400 | -41.7% |
 Hui Fai Tam Caitong International Asset Management Co. Ltd. | 7 | $30.8 | $23.59 | -$7.21 | -23.41% |
 Raymond Debbane Siren, L.L.C. | 435,798 | $3.47M | $1.72M | -$1.75M | -50.48% |
